Customers seeking diagnostics services from Pathologists Lancet Kenya now have an opportunity to access the same through Ponea Health, an e-commerce healthcare technology platform connecting healthcare service providers with patients.
Under this arrangement, patients will be able to book healthcare services through Ponea Health’s marketplace platform, Ponea.com in a move that will see Pathologists Lancet Kenya re-engineer its operations and service processes.
Commenting on the partnership, Pathologists Lancet Kenya Managing Director and CEO Mwende Musunga said that technological development has always influenced laboratory operations; and the current trend today is to offer flexibility in the delivery of laboratory services.
“We are excited about this partnership as it enables us to bring quality, reliable and accredited diagnostic services closer to people across the country. This new arrangement will provide a wide range of laboratory services to the patients’ doorsteps cost-effectively,” Musunga said.
Some of the laboratory tests that will be offered through the platform include screening and confirmatory tests for chronic diseases like diabetes, clinical chemistry studies- electrolyte studies, and tissue biopsy studies for potential malignancy.
On his part, Ponea Health Founder and Group Chief Visionary Officer, Michael Macharia said the addition of Lancet’s service catalogue to the portfolio further strengthens the delivery of unmatched convenience, efficiency, trust, and transparency to Ponea Health clients and gives new clients more confidence to access their healthcare services through a secure online platform.
“Partnering with Pathologists Lancet Kenya, an ISO-certified market leader in laboratory diagnostics, is a major boost towards our goal of democratizing healthcare. It will also spur transparency to medical testing and create a level playing field in laboratory testing, including for patients in remote parts of the country,” Mr. Macharia added
Read: Pathologists Lancet Kenya Announce Revision of COVID-19 Test Cost
>>> Lancet Confirms New Managing Director
Leave a comment